The Impact of a Helicopter Emergency Medical System on Prognosis in Stroke Patients

Sponsor
Rigshospitalet, Denmark (Other)
Overall Status
Completed
CT.gov ID
NCT02576379
Collaborator
(none)
1,068
63.9

Study Details

Study Description

Brief Summary

Stroke is a leading cause of death and disability, and 15 million people suffer a stroke each year; one-third die and one-third are left permanently disabled. Because the risk of stroke increases with age, it has been considered a disease of the elderly, but stroke also occurs in middle-aged people.

Thrombolysis with tissue plasminogen activator (tPA) is the preferred choice of reperfusion therapy of ischemic stroke if performed within 4.5 hours from symptom onset. Time to thrombolysis is associated with improved outcome: the sooner the treatment, the less risk of serious - and possibly permanent - damage to the brain. Unfortunately, only a small fraction of stroke patients make it to thrombolysis within the 4.5-hour; one explanation may be system delays including prolonged transportation.

In May 2010, the first physician-staffed Helicopter Emergency Medical Service (HEMS) was implemented in the Eastern part of Denmark. An observational study evaluating the short-term effects of HEMS implementation compared patients transported by conventional ground ambulance (Ground Emergency Medical Service (GEMS)) to patients transported by HEMS. Patients transported by helicopter had increased time to specialized care. However, both 30-day and 1-year mortality was slightly lower in patients transported by HEMS, although not significant, as was the degree of disability at three months measured by the modified Rankin Scale (mRS).

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    1068 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Impact of a Helicopter Emergency Medical System on Prognosis in Stroke Patients
    Study Start Date :
    Jan 1, 2010
    Actual Primary Completion Date :
    May 1, 2015
    Actual Study Completion Date :
    May 1, 2015

    Arms and Interventions

    Arm Intervention/Treatment
    HEMS patients

    Patients suspected of suffering from a vascular condition within the geographical area covered by both HEMS and GEMS, and were transported by Helicopter Emergency Medical System (HEMS) to the regional stroke unit at Copenhagen University Hospital Roskilde in a 36-month period from May 1st 2010 until April 30th 2013.

    GEMS patients

    Patients suspected of suffering from a vascular condition within the geographical area covered by both HEMS and GEMS, and were transported by Ground Emergency Medical System (GEMS) to the regional stroke unit at Copenhagen University Hospital Roskilde in a 40-month period from January 1st 2010 until April 30th 2013.

    Outcome Measures

    Primary Outcome Measures

    1. Risk of death during follow-up [2 - 5.5 years after admission to the stroke unit.]

      Mortality during the follow-up period will be analysed for differences between GEMS and HEMS. Follow-up period is until May 1st 2015. Because of varying access to information on covariates depending on the diagnosis and treatment of the patient, we conduct the analysis as follows: 1) the whole study population; adjusted for sex and age, 2) patients who were suspected of suffering from a vascular condition; adjusted for sex, age and comorbidity (defined as one of the following conditions; diabetes, atrial fibrillation, hypertension, previous myocardial infarction, and previous stroke), and 3) patients who underwent thrombolysis; adjustment for sex, age, comorbidity, and initial National Institutes of Health Stroke Scale (NIHSS) score.

    Secondary Outcome Measures

    1. The risk of death at 30 day. [30 days after admission to the stroke unit.]

      Patients are divided into the same three sub-groups and adjusted for the same potential confounders as described in the primary outcome analysis.

    2. Modified Rankin Scale (mRS) after three months. [Three months]

      Assessed in patients who underwent thrombolysis.

    3. The risk of involuntary early retirement during the follow-up period. [2 - 5.5 years after admission to the stroke unit.]

      Assessed in all patients suspected of suffering from a vascular condition between 18 and 60 years of age to ensure a sample that was at risk of involuntary early retirement during the full follow-up period.

    4. The risk of reduced workability two years after the vascular event [Two years after admission to the stroke unit]

      Assessed in all patients suspected of suffering from a vascular condition between 18 and 60 years of age to ensure a sample that was at risk of involuntary early retirement during the full follow-up period.

    5. The percentage of time on social transfer payments during the first two years. [Two years after admission to the stroke unit]

      Assessed in all patients suspected of suffering from a vascular condition between 18 and 60 years of age to ensure a sample that was at risk of involuntary early retirement during the full follow-up period.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All patients arriving at the regional stroke unit at Copenhagen University Hospital, Roskilde, suspected of an acute vascular condition within the geographical area covered by both HEMS and GEMS in a 40-month period from January 1st 2010 until April 30th 2013.
    Exclusion Criteria:
    • For patients with multiple contacts; only the first contact is included in the data for analysis.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Rigshospitalet, Denmark

    Investigators

    • Principal Investigator: Kamilia S. Funder, MD, Department of Anesthesia, Center of Head and Orthopedics, section 4231, Copenhagen University Hospital, Rigshospitalet
    • Study Director: Jacob Steinmetz, MD, PhD, Department of Anesthesia, Center of Head and Orthopedics, section 4231, Copenhagen University Hospital, Rigshospitalet

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Kamilia S. Funder, MD., Rigshospitalet, Denmark
    ClinicalTrials.gov Identifier:
    NCT02576379
    Other Study ID Numbers:
    • ALH3-KF-2015
    First Posted:
    Oct 15, 2015
    Last Update Posted:
    Jul 11, 2016
    Last Verified:
    Jul 1, 2016
    Keywords provided by Kamilia S. Funder, MD., Rigshospitalet, Denmark
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 11, 2016